1. Home
  2. MTCH vs STVN Comparison

MTCH vs STVN Comparison

Compare MTCH & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Match Group Inc.

MTCH

Match Group Inc.

HOLD

Current Price

$34.52

Market Cap

7.7B

Sector

Technology

ML Signal

HOLD

Logo Stevanato Group S.p.A.

STVN

Stevanato Group S.p.A.

HOLD

Current Price

$21.97

Market Cap

7.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
MTCH
STVN
Founded
1986
1949
Country
United States
Italy
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Containers/Packaging
Sector
Technology
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
7.7B
7.4B
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
MTCH
STVN
Price
$34.52
$21.97
Analyst Decision
Hold
Buy
Analyst Count
15
4
Target Price
$35.00
$25.38
AVG Volume (30 Days)
3.1M
370.9K
Earning Date
11-04-2025
11-06-2025
Dividend Yield
2.20%
0.28%
EPS Growth
N/A
19.61
EPS
2.15
0.60
Revenue
$3,469,367,000.00
$1,373,219,524.00
Revenue This Year
$2.06
$8.42
Revenue Next Year
$3.46
$9.52
P/E Ratio
$16.08
$36.99
Revenue Growth
N/A
6.97
52 Week Low
$26.39
$17.81
52 Week High
$39.20
$28.00

Technical Indicators

Market Signals
Indicator
MTCH
STVN
Relative Strength Index (RSI) 64.52 42.16
Support Level $33.35 $21.45
Resistance Level $34.23 $23.95
Average True Range (ATR) 0.68 1.18
MACD 0.27 0.08
Stochastic Oscillator 95.81 38.92

Price Performance

Historical Comparison
MTCH
STVN

About MTCH Match Group Inc.

Match Group Inc is a provider of online dating products. The company's portfolio of brands includes Tinder, Hinge, Match, Meetic, OkCupid, Pairs, Plenty Of Fish, Azar, BLK, and more, each built to increase its user's likelihood of connecting with others. The company has four operating segments: Tinder, Hinge, Evergreen and Emerging, and Match Group Asia. The company generates the majority of its revenue from the Tinder segment.

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

Share on Social Networks: